Chronic Pain Virtual Reality Therapy Market Report 2025

The chronic pain virtual reality therapy market size has grown exponentially in recent years. It will grow from $3.45 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 33%. The growth during the historic period is linked to increasing adoption of digital health solutions, rising prevalence of chronic pain conditions, growing acceptance of non-pharmacological therapies, and expanding clinical evidence supporting the efficacy of virtual reality (VR) interventions.

The chronic pain virtual reality therapy market size is expected to see exponential growth in the next few years. It will grow to $14.21 billion in 2029 at a compound annual growth rate (CAGR) of 32.7%. The growth projected for the forecast period is driven by increasing investment in healthcare innovation, rising demand for personalized and immersive therapies, expanding collaborations between technology firms and healthcare providers, and growing awareness of opioid-free pain management solutions. Primary trends during the forecast period include advancements in VR hardware, integration of artificial intelligence for personalized therapy, innovations in remote and home-based VR solutions, use of advanced data analytics for treatment outcomes, and incorporation with telehealth platforms.

The growing awareness and acceptance of virtual reality therapy are expected to support the expansion of the chronic pain virtual reality therapy market. Virtual reality therapy involves the use of immersive virtual environments to create interactive experiences for treatment and rehabilitation. The increase in awareness is attributed to the demonstrated effectiveness of virtual reality therapy in reducing pain and anxiety, offering a non-invasive and drug-free alternative that enhances patient experience and clinical outcomes. This growing familiarity with virtual reality therapy supports its application in chronic pain management by educating patients and clinicians about immersive treatment solutions and encouraging broader use. It also increases therapy participation by showcasing the effectiveness of virtual interventions in managing pain and improving overall well-being. For example, in July 2024, the U.S. Department of Veterans Affairs reported that approximately 3,500 virtual reality headsets had been deployed across more than 170 VA medical centers and outpatient clinics, tripling the number previously available for therapeutic use. This growing awareness and acceptance are contributing to the expansion of the chronic pain virtual reality therapy market.

Key companies in the chronic pain virtual reality therapy market are focusing on new advancements such as the immersive in-home therapy model to improve accessibility, increase long-term treatment participation, and provide scalable, cost-effective non-pharmacological pain management. The immersive in-home therapy model delivers structured and interactive virtual reality-based sessions for patients within their home environment. For instance, in May 2024, AppliedVR, a medical technology company in the United States, launched RelieVRx, a virtual reality therapy program developed for patients with chronic lower back pain under workers’ compensation. This prescription-based and FDA-authorized therapy offers a drug-free treatment option that extends access to pain management within home settings. RelieVRx delivers structured, skills-based therapeutic content designed to reduce pain intensity and minimize its impact on daily life. By targeting the workers’ compensation market, the program promotes faster recovery, improved functional outcomes, and return-to-work readiness. This introduction highlights the expanding role of virtual reality therapy as a safe, effective, and widely deployable solution for managing chronic pain without medication.

In April 2023, XRHealth Ltd., a therapeutic technology company based in the United States, merged with Amelia Virtual Care for an undisclosed amount. Through this merger, XRHealth plans to integrate Amelia’s clinician-oriented virtual reality software with its own virtual treatment-room operations to develop a comprehensive extended reality therapy platform that addresses physical rehabilitation, behavioral health, and chronic pain across diverse healthcare environments. Amelia Virtual Care is a health technology company headquartered in Spain that offers virtual reality therapy for chronic pain.

Major players in the chronic pain virtual reality therapy market are NHS Fife Pain Management Service, Torbay & South Devon NHS Foundation Trust, XRHealth Inc., AppliedVR Inc., Mieron VR, HypnoVR, KindVR, Waya Health, Flowly, CUREosity, Healium, Shine VR, Harvard MedTech, CognifiSense, Neuro Rehab VR Inc., Broomx Technologies, SyncVR Medical, Newel Health, Rocket VR Health, and Corpus VR.

North America was the largest region in the chronic pain virtual reality therapy market in 2024. The regions covered in chronic pain virtual reality therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the chronic pain virtual reality therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Chronic pain virtual reality (VR) therapy refers to the use of immersive VR technologies as a non-pharmacological intervention to manage and alleviate chronic pain. It creates engaging, interactive, and distraction-based virtual environments that help reduce pain perception, improve emotional well-being, and enhance overall quality of life. Its primary purpose is to complement traditional pain management strategies.

The primary components of chronic pain VR therapy include hardware, software, and services. Hardware refers to the physical devices and equipment used to deliver immersive VR experiences for pain management. Technologies utilized include non-immersive VR, semi-immersive VR, and fully immersive VR. Applications cover hospitals, clinics, home care, rehabilitation centers, and other healthcare settings. Key end users include adults, pediatric patients, and geriatric patients.

The chronic pain virtual reality therapy market research report is one of a series of new reports that provides chronic pain virtual reality therapy market statistics, including the chronic pain virtual reality therapy industry global market size, regional shares, competitors with the chronic pain virtual reality therapy market share, detailed chronic pain virtual reality therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic pain virtual reality therapy industry. This chronic pain virtual reality therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic pain virtual reality therapy market consists of revenues earned by entities by providing services such as virtual reality (VR)-based pain distraction sessions, integrative wellness services, specialized pain management, relaxation and mindfulness training, guided physical rehabilitation programs, and customized virtual environments. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic pain virtual reality therapy market also includes sales of virtual reality (VR) headsets, haptic feedback devices, motion sensors, outcome reporting dashboards, and clinical workflow products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.